Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: State of the issue

Histology and Histopathology

Volumn 19, Issue 2, 2004, Pages 575-583

  García Olmo, Damian C ^a   Ruiz Piqueras, R ^a   Garcia Olmo D ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cancer; Circulating nucleic acids; Metastasis; Stem cells

Indexed keywords

DNA; NUCLEIC ACID; RNA; TELOMERASE; TUMOR MARKER;

CANCER CELL; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL RENEWAL; CELL TRANSFORMATION; CELL TYPE; CIRCULATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; PATIENT MONITORING; PLASMA; PROTEIN EXPRESSION; REVIEW; SERUM; STEM CELL; TREATMENT OUTCOME; TUMOR GROWTH;

CELL LINE, TUMOR; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASMS; NUCLEIC ACIDS; STEM CELLS;

EID: 1842611093     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Anker P., Stroun M. and Maurice P.A. (1975). Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res. 35, 2375-2382.
2. Anker P., Lefort F., Vasioukhin V., Lyautey J., Lederrey C., Chen X.Q., Stroun M., Mulcahy H.E. and Farthing J.G. (1997). K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112, 1114-1120.
3. Anker P., Mulcahy H., Chen X.Q. and Stroun M. (1999). Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 18, 65-73.
4. Beau-Faller M., Gaub M.P., Schneider A., Ducrocq X., Massard G., Gasser B., Chenard M.P., Kessler R., Anker P., Stroun M., Weitzenblum E., Pauli G., Wihlm J.M., Quoix E. and Oudet P. (2003). Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int. J. Cancer 105, 361-370.
5. Bergsmedh A., Szeles A., Henriksson M., Bratt A., Folkman M.J., Spetz A.L. and Holmgren L. (2001). Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl. Acad. Sci. USA 98, 6407-6411.
6. Bernards R. and Weinberg R.A.(2002). Metastatic genes: A progression puzzle. Nature 418, 823.
7. Ceccarini M., Guidoni L., Luciani A.M., Mariutti G., Rosi A. and Viti V. (1989). Biochemical and NMR studies on structure and release conditions of RNA-containing vesicles shed by human colon adenocarcinoma cells. Int. J. Cancer 44, 714-721.
8. Chan K.C.A. and Lo Y.M.D. (2002). Circulating nucleic acids as a tumor marker. Histol. Histopathol. 17, 937-943.
9. Chan A.K.C., Chiu R.W.K. and Lo Y.M.D. (2003). Cell-free nucleic acids in plasma, serum and urine: A new tool in molecular diagnosis. Ann. Clin. Biochem. 40, 122-130.
10. Chen X.Q., Stroun M., Magnenat J.L., Nicod L.P., Kurt A.M., Lyautey J., Lederrey C. and Anker P. (1996). Microsatellite alterations in plasma DNA of small lung cancer patients. Nat. Med. 2, 1033-1035.
11. Chen X.Q., Bonnefoi H., Pelte M.F., Lyautey J., Lederrey C., Movarekhi S., Schaeffer P., Mulcahy H.E., Meyer P., Stroun M. and Anker P. (2000). Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin. Cancer Res. 6, 3823-3826.
12. Couzin J. (2003). Tracing the steps of Metastasis. Cancer's Menacing Ballet. Science 299, 1002-1006.
13. Dasí F., Lledó S., García-Granero E., Ripoll R., Marugán M., Tormo M., García-Conde J. and Aliño S.F. (2001). Real-tine quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: A simple blood test to monitor disease in cancer patients. Lab. Invest. 81, 767-769.
14. Dick J.E. (2003). Stem cells: Self-renewal writ in blood. Nature 423, 231-233.
15. Domen J. and Weissman I.L.(2000). Hematopoietic stem cells need two signals to prevent apoptosis; bcl-2 provide one of these, Kitl/c-kit signaling the other. J. Exp. Med. 192, 1707-1718.
16. Edwards P.A. (2002). Metastasis: The role of chance in malignancy. Nature 418, 823.
17. Fialkow P.J. (1979). Clonal origin of human tumors. Annu. Rev. Med. 30, 135-176.
18. Fidler I.J. and Kripke M.L. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893-895.
19. Fodde R., Smiths R. and Clevers H. (2001). APC, signal transduction and genetic instability in colorectal cancer. Nature Rev. Cancer 1, 55-67.
20. Folberg R., Rummelt V., Parys-Van Ginderdeuren R., Hwang T., Woolson R.F., Peer J. and Gruman L.M. (1993). The prognostic value of tumor blood vessels morphology in primary uveal melanoma. Ophthalmology 100, 1389-1398.
21. Fournie G.J., Courtin J.P., Laval F., Chale J.J., Pourrat J.P., Pujazon M.C., Lauque D. and Carles P. (1995). Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumors. Cancer Lett. 91, 221-227.
22. García-Olmo D., García-Olmo D.C., Ontañón J., Martinez E. and Vallejo M. (1999). Tumor DNA circulating in the plasma might play a role in metastasis. The hypothesis of the genometastasis. Histol. Histopathol. 14, 1159-1164.
23. García-Olmo D., García-Olmo D.C., Ontañón J. and Martinez E. (2000). Horizontal transfer of DNA and the " gEnometastasis hypothesis". Blood 95, 724-725.
24. García-Olmo D. and García-Olmo D.C. (2001). Functionality of circulating DNA: The hypothesis of genometastasis. Ann. N. Y. Acad. Sci. 945,265-75.
25. García-Olmo D., García-Arranz M., García L.G., Cuéllar E.S., Blanco I.F., Prianes L.A., Montes J.A., Pinto F.L., Marcos D.H. and García-Sancho L. (2003). Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: A new cell-based therapy. Int. J. Colorectal Dis. 18, 451-454.
26. Gatenby R.A. and Maini P. (2002). Modelling a new angle on understanding cancer. Nature 420, 462.
27. González R., Silva J.M., Sanchez A., Dominguez G., Garcia J.M., Chen X.Q., Stroun M., Provencio M., Espana P., Anker P. and Bonilla F. (2000). Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance. Ann. Oncol. 11, 1097-1104.
28. Greaves M.F. (1986). Differentiation-linked leukemogenesis in lymphocytes. Science 234, 697-704.
29. Hasselmann D.O., Rappl G., Tilgen W. and Reinhold U. (2001). Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem. 47, 1488-1489.
30. Hendrix M.J.C., Seftor E.A., Seftor R.E.B. and Trevor K.T. (1997). Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasion behaviour. Am. J. Pathol. 150, 483-495.
31. Hendrix M.J.C., Seftor E.A., Kirschmann D. and Seftor R.E.B. (2000). Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res. 2, 417-422.
32. Holmgren L., Szeles A., Rajnavölgyi E., Folkman J., Klein G., Emberg I. And Falk K.I. (1999). Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93, 3956-3963.
33. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D. and Knippers R. (2001). DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659-1665.
34. Jeronimo C., Nomoto S., Caballero O.L., Usadel H., Henrique R., Varzim G., Oliveira J., Lopes C., Fliss M.S. and Sidransky D. (2001). Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20, 5195-5198.
35. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-González X.R., Reyes M., Lenvik T, Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A. and Verfaillie C.M. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
36. Johnson P.J. and Lo Y.M.D. (2002). Plasma nucleic acids in the diagnosis and management of malignant disease. Clin. Chem. 48, 1186-1193.
37. Kondo S. (1983). Carcinogenesis in relation to the stem-cell-mutation hypothesis. Differentiation 24, 1-8.
38. Kopreski M.S., Benko F.A., Kwee C., Leitzel K.E., Eskander E., Lipton A. and Gocke C.D. (1997). Detection of mutant k-ras DNA in plasma or serum of patients with colorectal cancer. Br. J. Cancer 76, 1293-1299.
39. Kopreski M.S., Benko F.A., Kwak L.W. and Gocke C.D. (1999). Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5, 1961-1965.
40. Kopreski M.S., Benko F., Borys D.J., Khan A., McGarrity T.J. and Gocke C.D. (2000). Somatic mutation screening: Identification of individuals harbouring k-ras mutations with the use of plasma DNA. J. Nat. Cancer Inst. 92, 918-923.
41. Leon S.A., Shapiro B., Sklaroff D.M. and Yaros M.J. (1977). Free DNA in the serum of cancer patients an the effect of the therapy. Cancer Res. 37, 646-650.
42. Lessard J. and Sauvageau G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-60.
43. Lichtenstein A.V., Melkonyan H.S., Tomei L.D. and Umansky S.R. (2001). Circulating nucleic acids and apoptosis. Ann. N. Y. Acad. Sci. 945, 239-249.
44. Liotta A.L. and Kohn E.C. (2003). Cancer's deadly signature. Nat. Genet. 33, 10-11.
45. Lo Y.M.D. Epstein-Barr virus (EBV) DNA in plasma and serum as a tumor marker for EBV-associated malignancies. (2000). JHKMTA 8, 1-5.
46. Montell D.J. (2003). Border-cell Migration: The race is on. Nat. Rev. Mol. Cell. Biol. 14, 13-24.
47. Ng E.K.O., Tsui N.B.Y., Lam N.Y.L., Chiu R.W.K., Yu S.C.H., Wong S.C.C., Lo E.S.F., Rainer T.H., Johnson P.J. and Lo Y.M.D. (2002). Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48, 1212-1217.
48. Nguyen B., Elmore L.W. and Holt S.E. (2003). Telomerase as a target for cancer immunotherapy. Cancer Biol. Ther. 2, 131-136.
49. Nicolson G.L. (1991). Tumor and host molecules important in the organ preference of metastasis. Semin. Cancer Biol. 2, 143-154.
50. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J. and Clarke M.F. (2003) Bm-1 is required for mainteinance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305.
51. Pathak S. (2002). Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res. 22, 1353-1356.
52. Poste G. and Fidler I.J. (1980). The pathogenesis of cancer metastasis. Nature 283, 139-146.
53. Ramaswamy S., Tamayo P., Rifkin R., Mukherjee S., Yeang C.H., Angelo M., Ladd C., Reich M., Latulippe E., Mesirov J.P., Poggio T., Gerald W., Loda M., Lander E.S. and Golub T.R. (2001). Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. U.S.A. 98, 15149-15154.
54. Reddi K.K. and Holland J.F. (1976). Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Natl. Acad. Sci. USA 73, 2308-2310.
55. Reya T., Morrison S.J., Clarke M.F. and Weissman I.L. (2002). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
56. Rosi A., Guidoni L., Luciani A.M., Mariutti G. and Viti V. (1988). RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells. Cancer Lett. 39, 153-160.
57. Ryan B.M., McManus R.O., Daly J.S., Keeling P.W.N., Weir D.G., Lefort F. and Kelleher D. (2000). Serum mutant k-ras in the colorectal adenoma-to-carcinoma sequence. Implications for diagnosis, postoperative follow-up, and early detection of recurrent disease. Ann. N. Y. Acad. Sci. 906, 29-30.
58. Sawyers C.L., Denny C.T. and Witte O.N. (1991). Leukemia and the disruption of normal hematopoiesis. Cell 64, 337-350.
59. Screpanti I., Bellavia D., Campese A.F., Frati L. and Gulino A. (2003). Notch, a unifying target in T-cell acute lymphoblastic leukemia? Trends Mol. Med. 9, 30-35.
60. Seftor E.A., Meltzer P.S., Schatteman G.C., Gruman L.M., Hess A.R., Kirschmann D.A., Seftor R.E.B. and Hendrix M.J.C. (2002). Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: Role in vasculogenic mimicry. Crit. Rev. Oncol. Hematol. 44, 17-27.
61. Sell S. and Pierce G.B. (1994). Maturation of stem cell differentiation is a common pathway the cellular origin of tetrocarcinomas and epithelial cancers. Lab. Invest. 70, 6-22.
62. Sherley J.L. (2002). Metastasis: Objections to the same-gene model. Nature 419, 560.
63. Silva J.M., Domínguez G., Silva J., García J.M., Sánchez A., Rodríguez O., Provencio, M., España P. and Bonilla F. (2001). Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin. Cancer Res. 7, 2821-2825.
64. Silva J.M., Rodríguez R., García J.M., Muñoz C., Silva J., Domínguez G., Provencio, M., España P. and Bonilla F. (2002a). Detection of epithelial tumor RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumor cells. Gut 50, 530-534.
65. Silva J.M., Silva J., Sánchez A., García J.M., Domínguez G., Provencio M., Sanfrutos L., Jareño E., Colas A., España P. and Bonilla F. (2002b). Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival. Clin. Cancer Res. 8, 3761-3766.
66. Sorenson G.D. (2000). Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin. Cancer Res. 6, 2129-2137.
67. Sorenson G.D., Pribish D.M., Valone F.H., Memoli V.A., Bzik D.J. and Yao S.L. (1994). Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomark. Prev. 3, 67-71.
68. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., Pierotti M.A. and Tavecchio L. (2001). Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 61, 4675-4678.
69. Stroun M., Anker P., Beljanski M., Henri J., Lederrey C., Ojha M. and Maurice P.A. (1978). Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res. 38, 3546-3554.
70. Stroun M., Anker P., Lyautey J., Lederrey C. and Maurice P.A. (1987). Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol. 23, 707-712.
71. Stroun M., Anker P., Maurice P., Lyautey J., Lederrey C. and Beljanski M. (1989). Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46, 318-322.
72. Stroun M., Maurice P., Vasioukhin V., Lyautey J., Lederrey C., Lefort F., Rossier A., Chen X.Q. and Anker P. (2000). The origin and mechanism of circulating DNA. Ann. N. Y. Acad. Sci. 906, 161-168.
73. Stroun M., Lyautey J., Lederrey C., Mulcahy H.E. and Anker P. (2001). Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: Evidence for a preferential release from viable cells? Ann. N. Y. Acad. Sci. 945, 258-264
74. Taipale J. and Beachy P.A. (2001). The Hedgehog Wnt pathways in cancer. Nature 411, 349-54.
75. Temple S. (2001). The development of neural stem cells. Nature 414, 112-117.
76. Thomas P.A., Kirschmann D.A., Cerhan J.R., Folberg R., Seftor E.A., Sellers T.A. and Hendrix M.J.C. (1999). Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin. Cancer Res. 5, 2698-2703.
77. Till J.T. (1982). Stem cells in differentiation and neoplasia. Cell Physiol. 1, 3-11.
78. Trosko J.E. and Chang C.C. (1989). Stem cell theory of carcinogenesis. Toxicol. Letters 49, 283-295.
79. Tsai R.Y.L and McKay R.D.G. (2002). A nucleolar mechanism controlling ell proliferation in stem cells and cancer cells. Genes Dev. 16, 2991-3003.
80. Tu S.M., Lin S.H. and Logothetis C.J. (2002). Stem-cell origin of metastasis and heterogeneity in solid tumors. Lancet Oncol. 3, 508-513.
81. Vasioukhin V., Anker P., Maurice P., Lyautey J., Lederrey C. and Stroun M. (1994). Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br. J. Haematol. 86, 774-779.
82. Wang B.G., Huang H.Y., Chen Y.C., Bristow R.E., Kassauei K., Cheng C.C., Roden R., Sokoll L.J., Chan D.W. and Shih le M. (2003). Increased plasma DNA integrity in cancer patients. Cancer Res. 63, 3966-3968.
83. Wieczorek A.J., Rhyner C. and Block L.H. (1985). Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc. Natl. Acad. Sci. USA 82, 3455-3459.
84. Wieczorek A.J., Sitaramam V., Machleidt W., Rhyner K., Perruchoud A.P. and Block L.H. (1987). Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: First clinical evaluation of a novel tumor marker. Cancer Res. 47, 6407-6412.
85. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P. and Hedrick M.H. (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295.